ASAnat Shirvan

Anat Shirvan

*This is an algorithmically generated author record based on publicly available information.

Anat Shirvan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Ilan Ziv

    NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel

    2 shared publications
  • Ari Barzilai

    From the ‡Department of Neurology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, and the Sackler School of Medicine, Petach Tiqva 49100 and the ¶Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, the ‖Department of Cell Research and Immunology, and the **Sam Rothberg Glaucoma Center, Goldschleger Eye Research Institute, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel

    1 shared publication
  • Ari Barzilai

    Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel

    1 shared publication
  • Arieh S. Solomon

    From the ‡Department of Neurology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, and the Sackler School of Medicine, Petach Tiqva 49100 and the ¶Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, the ‖Department of Cell Research and Immunology, and the **Sam Rothberg Glaucoma Center, Goldschleger Eye Research Institute, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel

    1 shared publication
  • Avi Cohen

    NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel

    1 shared publication
  • Ayelet Reshef

    NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel

    1 shared publication

Latest Publications

  • Open Access

    Molecular imaging of cell death in vivo by a novel small molecule probe

    by Revital Aloya, Anat Shirvan, Hagit Grimberg, Ayelet Reshef, Galit Levin, Dvora Kidron, Avi Cohen, Ilan Ziv

    Apoptosis has a role in many medical disorders, therefore assessment of apoptosis in vivo can be highly useful for diagnosis, follow-up and evaluation of treatment efficacy. ApoSense is a novel technology, comprising low molecular-weight probes, specifically designed for imaging of cell death in vivo. In the current study we present targeting and imaging of cell death both in vitro and in vivo, utilizing NST-732, a member of the ApoSense family, comprising a fluorophore and a fluorine atom, for both fluorescent and future positron emission tomography (PET) studies using an 18F label, respectively. In vitro, NST-732 manifested selective and rapid accumulation within various cell types undergoing apoptosis. Its uptake was blocked by caspase inhibition, and occurred from the early stages of the apoptotic process, in parallel to binding of Annexin-V, caspase activation and alterations in mitochondrial membrane potential. In vivo, NST-732 manifested selective uptake into cells undergoing cell-death in several clinically-relevant models in rodents: (i) Cell-death induced in lymphoma by irradiation; (ii) Renal ischemia/reperfusion; (iii) Cerebral stroke. Uptake of NST-732 was well-correlated with histopathological assessment of cell-death. NST-732 therefore represents a novel class of small-molecule detectors of apoptosis, with potential useful applications in imaging of the cell death process both in vitro and in vivo.


    • 1 January 2003
      • Vol. 91, 73-82

    The molecular mechanisms of dopamine toxicity.

    by Ari Barzilai, Dorah Daily, Rina Zilkha-Falb, Ilan Ziv, Daniel Offen, Eldad Melamed, Anat Shirvan


  • Open Access

    Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy

    by Anat Shirvan, Michal Kimron, Vered Holdengreber, Ilan Ziv, Yehuda Ben-Shaul, Shlomo Melamed, Eldad Melamed, Ari Barzilai, Arieh S. Solomon